These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23370074)

  • 1. Botulinum toxin A in postherpetic neuralgia: a parallel, randomized, double-blind, single-dose, placebo-controlled trial.
    Apalla Z; Sotiriou E; Lallas A; Lazaridou E; Ioannides D
    Clin J Pain; 2013 Oct; 29(10):857-64. PubMed ID: 23370074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Rauck RL; Irving GA; Wallace MS; Vanhove GF; Sweeney M
    J Pain Symptom Manage; 2013 Aug; 46(2):219-28. PubMed ID: 23149085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial.
    Wu CJ; Lian YJ; Zheng YK; Zhang HF; Chen Y; Xie NC; Wang LJ
    Cephalalgia; 2012 Apr; 32(6):443-50. PubMed ID: 22492424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
    Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
    J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.
    Xiao L; Mackey S; Hui H; Xong D; Zhang Q; Zhang D
    Pain Med; 2010 Dec; 11(12):1827-33. PubMed ID: 21134121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (PXN110748).
    Zhang L; Rainka M; Freeman R; Harden RN; Bell CF; Chen C; Graff O; Harding K; Hunter S; Kavanagh S; Laurijssens B; Schwartzbach C; Warren S; McClung C
    J Pain; 2013 Jun; 14(6):590-603. PubMed ID: 23602345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous botulinum toxin-A injection for treating postherpetic neuralgia.
    Hu Y; Zou L; Qi X; Lu Y; Zhou X; Mao Z; Chen X; Liu K; Yang Y; Wu Z; Hu Y; Ma S
    Dermatol Ther; 2020 Jan; 33(1):e13181. PubMed ID: 31769900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN).
    Sang CN; Sathyanarayana R; Sweeney M;
    Clin J Pain; 2013 Apr; 29(4):281-8. PubMed ID: 22801243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute treatment of trigeminal neuralgia with onabotulinum toxin A.
    Zúñiga C; Piedimonte F; Díaz S; Micheli F
    Clin Neuropharmacol; 2013; 36(5):146-50. PubMed ID: 24045604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial.
    Gilron I; Wajsbrot D; Therrien F; Lemay J
    Clin J Pain; 2011; 27(3):185-93. PubMed ID: 21178603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled trial of a selective COX-2 inhibitor, GW406381, in patients with postherpetic neuralgia.
    Shackelford S; Rauck R; Quessy S; Blum D; Hodge R; Philipson R
    J Pain; 2009 Jun; 10(6):654-60. PubMed ID: 19409858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships Among Pain Quality, Pain Impact, and Overall Improvement in Patients with Postherpetic Neuralgia Treated with Gastroretentive Gabapentin.
    Freeman R; Wallace MS; Sweeney M; Backonja MM
    Pain Med; 2015 Oct; 16(10):2000-11. PubMed ID: 26115203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.
    Backonja M; Wallace MS; Blonsky ER; Cutler BJ; Malan P; Rauck R; Tobias J;
    Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
    Seo HG; Bang MS; Chung SG; Jung SH; Lee SU
    Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Pregabalin for Postherpetic Neuralgia in a Population of Chinese Patients.
    Liu Q; Chen H; Xi L; Hong Z; He L; Fu Y; Fang H; Shang N; Yan P; Fan D
    Pain Pract; 2017 Jan; 17(1):62-69. PubMed ID: 26714731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial.
    Irving G; Jensen M; Cramer M; Wu J; Chiang YK; Tark M; Wallace M
    Clin J Pain; 2009; 25(3):185-92. PubMed ID: 19333167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design.
    Cousins MJ; Pickthorn K; Huang S; Critchley L; Bell G
    Pain Med; 2013 Apr; 14(4):533-40. PubMed ID: 23438341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early pain reduction can predict treatment response: results of integrated efficacy analyses of a once-daily gastroretentive formulation of gabapentin in patients with postherpetic neuralgia.
    Jensen MP; Hsu PH; Vanhove GF
    Pain Med; 2012 Aug; 13(8):1059-66. PubMed ID: 22757655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.